血小板单细胞聚合物在川崎病中诱发炎症和血管病变
Yuan Zhang1, Cuiping Jia1, Manli Guo1
1Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|December 12, 2024
概括
川崎病涉及血小板-单细胞相互作用驱动炎症. 针对这些相互作用,如P-selectin和TGF-β1,可以预防儿童血管病变.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 儿童心脏病学 儿童心脏病学
背景情况:
- 川崎病 (KD) 是儿童的一种严重疾病,其特征是全身性血管炎和潜在的冠状动脉动脉瘤.
- 血小板过敏反应和免疫失调是KD的标志,但血小板在KD病原发生中的确切作用尚未完全理解.
- 了解血小板-单细胞相互作用对于阐明KD诱导的炎症和血管病变至关重要.
研究的目的:
- 为了研究川崎病中血小板单细胞聚合的机制.
- 为了确定关键的分子相互作用和细胞因子介质参与KD病变的产生.
- 探索预防KD相关血管病变的潜在治疗点.
主要方法:
- 在KD患者中分析血小板单细胞聚合物 (MPAs).
- 研究P-选择素 (CD62p) /PSGL-1和GPIbα/CD11b的相互作用.
- 评估转化生长因子-β1 (TGF-β1) 在单细胞中的信号传递.
- 评估单细胞表型转换 (CD14+CD16-) 到促炎性 (CD14+CD16+) 状态.
- 使用缺乏血小板TGF-β1的小鼠模型来评估体内效应.
主要成果:
- 确定了KD血小板和单细胞之间的积极反循环,由特定的粘附分子介导.
- KD MPAs涉及CD62p/PSGL-1和GPIbα/CD11b的连续相互作用.
- 血小板衍生的TGF-β1诱导核因子kappaB在单细胞中的局部化,促进它们的亲炎性表型.
- 抑制这种反循环的组件可以防止KD诱导的炎症和血管病变.
- 缺乏血小板TGF-β1的小鼠表现出降低的MPA,较少的促炎单细胞和减少的血管病变.
结论:
- 血小板 - 单细胞相互作用在川崎病中形成了关键的细胞因子介导的积极反循环.
- 特定的血小板蛋白 (CD62p,GPIbα) 和单细胞受体 (PSGL-1,CD11b) 是这些相互作用的关键介质.
- 血小板TGF-β1在驱动单细胞激活和KD血管病变方面发挥着重要作用.
- 向血小板单细胞相互作用蛋白和TGF-β1为KD血管病变提供了有前途的治疗策略.
相关概念视频
Formation of the Platelet Plug
4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K
Inflammation
52.6K
Overview
52.6K
Structure and Function of Platelets
988
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
988
Clot Retraction and Fibrinolysis
4.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.0K
Extrinsic and Intrinsic Pathways of Hemostasis
5.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.5K


